Mitchell W. Krucoff

Mitchell W. Krucoff's AcademicInfluence.com Rankings

Mitchell W. Krucoff

Philosophy

#6840

World Rank

#9947

Historical Rank

Logic

#3942

World Rank

#5176

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Mitchell W. Krucoff Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mitchell W. Krucoff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions (2007) (5088)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium (2011) (3111)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. (2014) (1564)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
Outcomes of anatomical versus functional testing for coronary artery disease. (2015) (1126)
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium† (2010) (975)
Incidence (1931) (868)
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. (2011) (842)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young (2004) (512)
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. (1997) (387)
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. (2016) (365)
Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial (2005) (341)
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. (2005) (322)
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention (2019) (293)
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. (2001) (284)
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes With Bypass: A Multicenter, Randomized Trial (2001) (277)
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (268)
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk (2019) (266)
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. (2009) (253)
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). (2015) (243)
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (228)
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. (1986) (226)
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. (2014) (221)
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. (1995) (218)
The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. (2009) (187)
Best practices for transradial angiography and intervention: A consensus statement from the society for cardiovascular angiography and intervention's transradial working group (2014) (186)
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. (1993) (173)
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study (2005) (173)
Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion (1993) (168)
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. (2015) (164)
Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. (1996) (164)
The Learning Curve for Transradial Percutaneous Coronary Intervention Among Operators in the United States: A Study From the National Cardiovascular Data Registry (2014) (163)
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. (2000) (157)
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). (2005) (136)
Thrombosis and drug-eluting stents: an objective appraisal. (2007) (129)
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis (2012) (128)
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. (2008) (123)
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. (2002) (122)
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery. (1988) (122)
Percutaneous atrial Septal Occluder devices and cardiac erosion: A review of the literature (2012) (120)
PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. (2014) (120)
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. (1998) (119)
The truth and consequences of the COURAGE trial. (2007) (119)
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). (2007) (119)
Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. (2009) (111)
The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion. (1990) (111)
Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. (1996) (109)
A Reevaluation of the Costs of Heart Failure and Its Implications for Allocation of Health Resources in the United States (2014) (108)
AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society o (2005) (105)
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. (2007) (104)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. (2016) (103)
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). (2007) (102)
Effect of Supersaturated Oxygen Delivery on Infarct Size After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2009) (100)
Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. (2001) (95)
Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. (2016) (94)
Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST- Segment Monitoring Practice Guideline International Working Group. (1999) (94)
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). (2004) (90)
Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. (2012) (88)
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). (2007) (88)
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th (2001) (83)
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. (2014) (81)
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. (1998) (80)
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (77)
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries. (2002) (77)
Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. (2011) (76)
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. (1990) (75)
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. (2017) (75)
Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study. (2006) (74)
The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. (2015) (72)
Novel oral anticoagulants and reversal agents: Considerations for clinical development. (2015) (71)
Ventricular arrhythmias during reperfusion. (1986) (70)
Intracoronary ultrasound evaluation of interventional technologies. (1991) (68)
Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion. (1988) (68)
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. (2005) (68)
Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). (2013) (67)
ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. (2000) (66)
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. (2016) (66)
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction. (2016) (64)
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials (2015) (64)
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. (2002) (64)
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. (2021) (61)
Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial in (2009) (61)
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium. (2015) (59)
Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies. (1997) (59)
A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). (2011) (59)
Paced QRS duration as a predictor for clinical heart failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block: results from an observational cohort study (PREDICT‐HF) (2013) (58)
Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention (2015) (57)
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group. (1994) (54)
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. (2016) (54)
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative (2018) (52)
Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. (1998) (52)
Instrumentation and practice standards for electrocardiographic monitoring in special care units. A report for health professionals by a Task Force of the Council on Clinical Cardiology, American Heart Association. (1989) (49)
Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring. (1988) (49)
Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks. (2015) (49)
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. (2008) (47)
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction. (2008) (45)
QT prolongation and dispersion in myocardial ischemia and infarction. (1998) (43)
Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. (2009) (42)
Postmarket evaluation of breakthrough technologies. (2008) (41)
Autopsy validation study of the academic research consortium stent thrombosis definition. (2011) (41)
Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis. (1999) (40)
Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective. (2012) (39)
Computer-assisted ST-segment monitoring: experience during and after brief coronary occlusion. (1987) (39)
The touch that heals: the uses and meanings of touch in the clinical encounter. (2008) (39)
Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial. (2004) (39)
Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. (2011) (38)
Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy. (2015) (37)
Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction. (2007) (37)
Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. (2001) (36)
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). (2000) (36)
Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias. (2008) (35)
Simultaneous ST-segment measurements using standard and monitoring-compatible torso limb lead placements at rest and during coronary occlusion. (1994) (35)
Electrocardiographic assessment for therapeutic proteins--scientific discussion. (2010) (34)
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2015) (34)
The academic research consortium governance charter. (2011) (34)
Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (34)
Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function. (2003) (34)
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. (2021) (33)
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries. (1989) (33)
Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. (2006) (33)
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. (2004) (32)
Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study (2009) (32)
A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVA (2015) (31)
Acute results, complications, and effect of lesion characteristics on outcome with the solid‐state, pulsed‐wave, mid‐infrared laser angioplasty system: Final multicenter registry report (1998) (30)
Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors. (1995) (30)
Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis. (2012) (30)
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary int (2010) (30)
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. (2004) (29)
Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. (2004) (29)
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation. (2021) (28)
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing. (2010) (27)
More Complete and Stable Reperfusion with Platelet IIb/IIIa Antagonism Plus Thrombolysis for AMI: The PARADIGM Trial (1996) (27)
Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database. (2010) (27)
Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty. (1990) (27)
A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of (1999) (27)
Treatment of long coronary artery narrowings with long angioplasty balloon catheters. (1993) (26)
Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion. (2005) (26)
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. (2020) (25)
Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block. (1991) (25)
Comparison of Electrocardiogram and Intrathoracic Electrogram Signals for Detection of Ischemic ST Segment Changes During Normal Sinus and Ventricular Paced Rhythms (2002) (24)
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium (2020) (24)
Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: The RAPSODY trial (2003) (24)
Commentary: International collaboration needed on device clinical standards (2011) (24)
Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery. (2008) (24)
New precompetitive paradigms: focus on cardiac safety. (2009) (24)
Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study (1994) (23)
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction. (1997) (23)
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators. (1996) (22)
Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. (2019) (22)
Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions. (2013) (22)
Implications of ventricular arrhythmia “bursts” with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: A biosignature of direct myocellular injury “downstream of downstream” (2015) (22)
The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. (2013) (22)
Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination. (2006) (22)
From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP). (2006) (21)
Clinical application of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty (1993) (21)
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
Pediatric cardiovascular safety: challenges in drug and device development and clinical application. (2012) (21)
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. (2019) (20)
Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials (2013) (19)
Incremental benefit of 80-lead electrocardiogram body surface mapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST-elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myo (2010) (19)
Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans. (1992) (19)
Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? (2006) (19)
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial. (2020) (19)
Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements. (2018) (19)
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). (2005) (18)
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. (2010) (18)
Myocardial salvage after failed coronary angioplasty. (1990) (18)
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. (2004) (18)
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion (2002) (18)
The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents. (2007) (18)
Feasibility and applicability of computer‐assisted myocardial blush quantification after primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction (2010) (18)
Clinical outcomes in real‐world patients with small vessel disease treated with XIENCE V® everolimus‐eluting stents: One year results from the XIENCE V® USA condition of approval post‐market study (2014) (17)
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). (2008) (17)
Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial). (2003) (17)
1059-23 Cell location may be a primary determinant of safety after myoblast transplantation into the infarcted heart (2004) (16)
Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (16)
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents (2020) (16)
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI. (2021) (16)
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
Poor performance of lead V5 in single- and dual-channel ST-segment monitoring during coronary occlusion. (1988) (16)
Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database. (2012) (16)
Drug-eluting stents "deliver heartburn": how do we spell relief going forward? (2007) (15)
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk (2020) (15)
Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion. (1996) (15)
Teaching yoga to seniors: essential considerations to enhance safety and reduce risk in a uniquely vulnerable age group. (2010) (15)
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion. (2008) (15)
RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. (2010) (15)
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor (2000) (14)
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
Electrocardiographic monitoring and coronary occlusion. Fingerprint pattern analysis in dimensions of space, time, and mind. (1989) (14)
Healing prayer outcomes studies: consensus recommendations. (2003) (14)
Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events (2019) (14)
Cardiovascular events and hospital resource utilization pre– and post–transcatheter mitral valve repair in high–surgical risk patients (2017) (14)
New Medical Technologies in a Cost Containment Environment: Implantahle Antitachyarrhythmia Devices * (1987) (13)
Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: The Rinspiration international registry (2008) (13)
Clinical outcomes in real‐world patients with bifurcation lesions receiving Xience V everolimus‐eluting stents: Four‐year results from the Xience V USA study (2016) (12)
A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy. (2005) (12)
Embedding clinical interventions into observational studies. (2016) (12)
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial. (2009) (12)
Cardiac remodeling after large ST-elevation myocardial infarction in the current therapeutic era. (2020) (12)
Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations. (2008) (12)
ST-segment monitoring in patients with acute coronary syndromes (2003) (11)
Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. (2018) (11)
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. (2020) (11)
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies (2020) (11)
Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging. (2011) (11)
The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. (2016) (11)
Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion. (2004) (11)
"Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. (2003) (11)
Correlations Between Preprocedure Mood and Clinical Outcome in Patients Undergoing Coronary Angioplasty (2003) (10)
Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations. (1993) (10)
Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. (1993) (10)
Advancing medical device innovation through collaboration and coordination of structured data capture pilots: Report from the Medical Device Epidemiology Network (MDEpiNet) Specific, Measurable, Achievable, Results-Oriented, Time Bound (SMART) Think Tank. (2017) (10)
Radial First: Paradox+Proficiency=Opportunity (2013) (9)
Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia. (2004) (9)
Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI. (2015) (9)
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. (2009) (9)
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel‐Coated Devices: Insights From the Veterans Health Administration (2021) (9)
Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. (2012) (9)
Should rhythm control be preferred in younger atrial fibrillation patients? (2012) (9)
Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring. (1990) (9)
Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events. (2019) (9)
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) (8)
Simultaneous platelet glycoprotein IIb/IIIa integrin blockade and front-loaded tissue plasminogen activator in acute myocardial infarction: Results from a randomized trial (1996) (8)
Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. (2019) (8)
Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI. (2016) (8)
What do "we" want and need to know about prayer and healing? (2009) (8)
Resolution of ST-segment elevation 90 minutes after thrombolysis for acute myocardial infarction predicts outcome: a GUSTO-III substudy (1998) (8)
Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design. (1990) (8)
Electrocardiographic Safety of Cangrelor, a New Intravenous Antiplatelet Agent: A Randomized, Double-blind, Placebo- and Moxifloxacin-controlled Thorough QT Study (2013) (8)
Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies (2019) (8)
Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. (2012) (8)
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. (2019) (8)
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial. (2020) (8)
Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial (2010) (7)
Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery. (2000) (7)
Toward a more materialistic medicine: the value of authentic materialism within current and future medical practice. (2011) (7)
Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction (2019) (7)
Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: a randomized, prospective clinical investigation. (2014) (7)
QRS changes during acute ischemia induced by balloon occlusion of the LAD artery. (1988) (7)
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. (2002) (7)
Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet). (2016) (7)
Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration". (2006) (7)
Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms. (2019) (7)
Evolution of an automated ST-segment analysis program for dynamic real-time, noninvasive detection of coronary occlusion and reperfusion. (1992) (6)
Computer‐assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast‐enhanced cardiovascular magnetic resonance outcomes in patients with ST‐segment elevation myocardial infarction (2011) (6)
St Segment Changes during Early Myocardial Infarction (1987) (6)
Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative. (2005) (6)
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. (1999) (6)
Growing the path to the patient: an editorial outlook for Alternative therapies. (2000) (6)
Continuous computer-assisted electrocardiographic monitoring in patients with acute myocardial infarction: early experience (1989) (6)
Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging (2018) (6)
Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients (2016) (6)
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial. (2022) (6)
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
Dedicated ST-segment monitoring in the CCU after successful coronary angioplasty: incidence and prognosis of silent and symptomatic ischemia (1987) (6)
Registry Assessment of Peripheral Interventional Devices (RAPID)　- Registry Assessment of Peripheral Interventional Devices Core Data Elements. (2018) (6)
Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium (2017) (5)
Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol. (1989) (5)
Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36. (2009) (5)
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. (2013) (5)
Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)) (2015) (5)
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium. (2020) (5)
Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. (2014) (5)
"Hugging balloons" through a single 8-French guide: salvage angioplasty with lytic therapy in the infarct vessel of a 40-year-old man. (1991) (5)
The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium (2018) (5)
The impact of autoperfusion on quantitative electrocardiographic parameters of ischemia severity, extent, and "burden" during salvage of elective coronary angioplasty. (1994) (4)
Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios? (2019) (4)
Important Considerations for Trials for Peripheral Arterial Disease: Lessons Learned from the Paclitaxel Mortality Signal: A Report on behalf of the Registry Assessment for Peripheral Interventional. (2020) (4)
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction. (2021) (4)
Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. (2014) (4)
Instrumentation and Practice Standards for Electrocardiographic Monitoring (2005) (4)
Focus on the Cardiac Safety Research Consortium (2011) (4)
Real-time application of continuous 12-lead ST-segment monitoring: 3 case studies. (2000) (4)
ST-segment recovery as an endpoint in acute myocardial infarction trials. Past, present, and future. (1993) (4)
Reassessing the clinical significance of ST-segment depression that occurs concomitantly with the ST-segment elevation during acute myocardial infarction with the use of continuous ST-segment analysis. (1994) (4)
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
Quantitation of ischemia during total coronary occlusion with computer-assisted high resolution ST-segment monitoring: effect of collateral flow. (1987) (4)
Treatment of non-cardiogenic pulmonary edema following cardiopulmonary bypass with veno-venous extracorporeal membrane oxygenation. (1988) (4)
From ST-elevation myocardial infarction to ST elevation with no myocardial infarction--review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices. (2009) (4)
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
The Abciximab ST-Recovery on AMI (ASTRONAMI) GUSTO V substudy: enhanced early speed, stability, and quality of reperfusion with anti-pletelet augmented thrombolytic therapy for ST-elevation AMI (2002) (4)
"Take your pill": the role and fantasy of pills in modern medicine. (2014) (3)
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women. (2019) (3)
Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. (2008) (3)
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY (2011) (3)
Arterial and Venous Access and Hemostasis for PCI (2013) (3)
Age, STEMI, and Cardiogenic Shock: Never Too Old for PCI? (2019) (3)
Overview of complementary and alternative medicine Chun-Su Yuan Eric J (2003) (3)
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts. (2016) (3)
Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association–cardiac safety research consortium cosponsored think tank (2017) (3)
Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. (2018) (3)
Abstract 26: Comparison of Medicare Claims with Clinical Trial Outcomes for Follow-up of Older Individuals with Acute Coronary Syndrome (2014) (3)
Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study (2021) (3)
Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial. (2019) (3)
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy (2022) (3)
ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT (2018) (3)
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2017) (3)
Noninvasive assessment of patients following coronary artery angioplasty. (1988) (3)
The comparison of epicardial focused ultrasound circumferential pulmonary vein ablation and BOX ablation—results from experimental acute atrial fibrillation (2012) (3)
Performance Goal Criteria for Device Evaluation in Lower Extremity Peripheral Vascular Intervention and the Need for Standardized Data Structure: What Is the Sound of One Hand Clapping? (2018) (3)
The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. (2011) (3)
Transradial PCI in women: problem solved or clinical equipoise? (2011) (3)
From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring. (1994) (3)
Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients. (2020) (3)
COMPARISON OF RATES OF BLEEDING AND VASCULAR COMPLICATIONS BEFORE, DURING, AND AFTER TRIAL ENROLLMENT IN THE SAFE-PCI TRIAL FOR WOMEN (2018) (3)
2: Early Objective Identification of Chest Pain Patients at Very Low Risk of 30-Day Adverse Outcomes (2009) (2)
Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. (2001) (2)
MAGNITUDE AND DURATION OF INTRACARDIAC ST-SEGMENT CHANGES FOR CONFIRMED CLINICAL EVENTS: FIRST IN-MAN EXPERIENCE (2012) (2)
Current Approaches to Prevention and Management of Reperfusion Injury (2012) (2)
Thrombin and fibrin activity in patients treated with enoxaparin, ticlopidine and aspirin versus the conventional coumadin regimen after elective stenting: The ENTICES trial (1996) (2)
A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine (2018) (2)
Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis. (2008) (2)
Japan-USA orbital atherectomy for calcific coronary lesions: COAST study, Hharmonization by Doing proof-of-concept. (2021) (2)
Compliance of balloon material does not effect angiographic dissection rate. Results from the CRAC(Compliant Related Acute Complication) study (1996) (2)
WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
Evidence strength in FDA premarket approval of cardiovascular devices. (2010) (2)
Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs (2020) (2)
ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug‐eluting stent study cohorts (2018) (2)
737–6 Combining Myoglobin and Clinical Variables for Assessing Coronary Reperfusion After Thrombolytic Therapy (1995) (2)
QUANTIFICATION OF AMPLITUDE, SPEED AND COMPLETENESS OF ST-SEGMENT RECOVERY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: WHAT IS THE “BEST ST” RECOVERY TO PREDICT CLINICAL OUTCOME? (2010) (2)
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies (2021) (2)
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. (2022) (2)
Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease. (2011) (2)
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents (2020) (2)
SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention. (2020) (2)
ST-segment parameters and the GUSTO-I mortality model: another risk-stratification tool in acute myocardial infarction (1998) (1)
One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape (2022) (1)
Maximum likelihood estimation of time to first event in the presence of data gaps and multiple events (2016) (1)
The first ISCE board of [ldquo ]Trustees[rdquo ] overview panel session: Ischemia monitoring, state of the art (2002) (1)
Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation. (2007) (1)
Conversations in Cardiology (2014) (1)
Abstract 4156: Comparison of Sirolimus-Eluting NEVOTM Stents With Paclitaxel-eluting CoStarTM Stents and Paclitaxel-eluting Taxus LiberteTM Stents: Insights From Intravascular Ultrasound Analysis of the Res-elution I and Costar II Trials (2009) (1)
TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials (2018) (1)
Patients Accept Mortality Risk for Improvements in Physical Functioning in Secondary Mitral Regurgitation (2019) (1)
1000–37 The “Long Long” Balloon Pilot: Dilatation of Class C Coronary Lesions Using Slow, Oscillating, Prolonged Inflation of 40 mm Balloons (1995) (1)
Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement. (2017) (1)
Relax into Yoga for Seniors: An Evidence-Informed Update for Enhancing Yoga Practice Benefits by Reducing Risk in a Uniquely Vulnerable Age Group (2021) (1)
Simultaneous restenosis of Taxus and Cypher drug-eluting stents. (2006) (1)
Abstract 18405: Low Clinical Event Rates in Real-World Patients with Bifurcation Lesions Receiving XIENCE V® Everolimus-Eluting Stents: One-Year Results from the XIENCE V USA Study (2010) (1)
Cardiac Safety Research Consortium (CSRC) (2015) (1)
Mitchell W. Krucoff, MD. The MANTRA Study Project. Interview by Bonnie Horrigan. (1999) (1)
ACCF Complementary Medicine Expert Consensus Document — Online Appendices Integrating Complementary Medicine Into Cardiovascular Medicine (2005) (1)
SURVIVAL IN PATIENTS WITH MODERATE OR SEVERE MITRAL REGURGITATION AT HIGH RISK FOR SURGERY TREATED WITH AND WITHOUT THE MITRACLIP: A PROPENSITY MATCHED COMPARISON (2012) (1)
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. (2022) (1)
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. (2021) (1)
Standards need international collaboration (2011) (1)
Abstract 1768: Effect of Pre-Hospital 12-Lead ST-Segment Monitoring on Time to Treatment in Acute Coronary Syndrome: The ST SMART Study (2006) (1)
Ventricular arrhythmia bursts following primary percutaneous coronary intervention for acute myocardial infarction: correlations with microvascular obstruction and final infarct size using CMR (2013) (1)
Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary (2017) (1)
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials* (2005) (1)
Healing Moves: How to Cure, Relieve, and Prevent Common Ailments with Exercise (2000) (1)
Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents. (2012) (1)
Quantitative ST-segment recovery following angiographically successful angioplasty: a useful warning of early complications. (1988) (1)
Unstable infarct artery. Quantification across angiographic subgroups using continuous digital 12-lead ST-segment recovery analysis. (1992) (1)
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. (2022) (0)
Reply: Transradial PCI in Women: Zeroing in on Crossovers. (2015) (0)
Reply: Improving the Patient Relevance and Generalizability of TAVR Core Data Elements. (2022) (0)
Evaluation and Treatment of Patients With Lower Extremity Peripheral ArteryDisease (2015) (0)
The first ISCE Board of "Trustees" overview panel session: ischemia monitoring, state of the art. International Society of Computerized Electrocardiology. (2002) (0)
TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women : Results of the SAFE-PCI for Women Quality-of-Life Substudy (2015) (0)
“Over The Shoulder” Guidewire Manipulation Through An Angulated Stenosis Adjacent To A Coronary Aneurysm During High Risk Percutaneous Transluminal Angioplasty (1992) (0)
The use of digital real-time 12-lead ST segment trends in the management of acute myocardial infarction patients during helicopter transport and early hospitalization (1989) (0)
CONTINUOUS 12-LEAD ST-SEGMENT RECOVERY PREDICTS OUTCOME IN ACUTE MYOCARDIAL INFARCTION BETTER THAN SNAPSHOT ANGIOGRAMS OF TIMI FLOW (1998) (0)
Abstract 2398: The Role of RR-Interval Variability Preceding Ventricular Fibrillation in ST Elevation Acute Myocardial Infarction (2007) (0)
ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Comparison of published ST recovery analysis methods to predict clinical outcome in acute myocardial infarction using a single digital continuous 12-lead ECG data set (1999) (0)
Cardiovascular Disease in the Young : Endorsed by the American Heart Association Scientific Statement From the Councils on Cardiovascular Practice Standards for Electrocardiographic Monitoring in Hospital Settings : An Print (2004) (0)
Pharmacodynamic Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: A Prespecified Subanalysis of The COMPARE CRUSH Trial (2021) (0)
Coronary heart disease Reperfusion ventricular arrhythmia ‘ bursts ’ predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction (2009) (0)
Registry Assessment of Peripheral Interventional Devices Objective Performance Goals for Superficial Femoral and Popliteal Artery Peripheral Vascular Interventions. (2020) (0)
Abstract 14749: Anatomic and Physiologic Determinants of the Area-at-Risk Differentiate in Range of Infarct Size among Patients Undergoing Primary Percutaneous Coronary Intervention (2012) (0)
Changes in coronary patency with continuous 12-lead st segment monitoring during transport and early management of acute myocardial infarction patients (1989) (0)
Device implementation, validation, and application assessment of two continuous 12-lead ECG monitors during percutaneous transluminal coronary angioplasty: description of the validation method and implications for clinical trials. (1998) (0)
VENTRICULAR ARRHYTHMIA BURSTS FOLLOWING PRIMARY PCI FOR ACUTE MYOCARDIAL INFARCTION: CORRELATIONS WITH CMRI OF MICROVASCULAR OBSTRUCTION AND FINAL INFARCT SIZE (2013) (0)
CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart Center. (1991) (0)
Twelve lead real-times ST segment monitoring during helicopter transport of acute myocardial infarction patients after thrombolytic therapy (1989) (0)
AS-46: Randomized Comparison of Primary Percutaneous Coronary Intervention with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary Percutaneous Coronary Intervention Alone in ST-segment Elevation Myocardial Infarction (2009) (0)
Editorial: Radial to Coronary: Ideal Catheter for the Ideal Approach. (2017) (0)
Predictable And SuStainable Implementation Of National Cardiovascular Registries Infrastructure: A Think Tank Report from MDEpiNet (2015) (0)
Global medical device clinical trials involving both the United States and Japan: Key considerations for development, regulatory approval, and conduct. (2023) (0)
1003-93 Outcomes prediction with continuous 12-lead ST-segment recovery in ST elevation myocardial infarction: Similarities or differences with thrombolytic versus direct stenting populations? (2004) (0)
Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank. (2020) (0)
TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry (2020) (0)
Conversation in cardiology: Should FFR and IVUS be counted as PCI? (2013) (0)
Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy Short title: Hess et al.: QOL in SAFE-PCI for Women (2015) (0)
New applications of computer assisted ST segment analysis (1986) (0)
mproved Speed and Stability f ST-Segment Recovery With educed-Dose Tenecteplase and Eptifibatide ompared With Full-Dose Tenecteplase for cute ST-Segment Elevation Myocardial Infarction (2016) (0)
Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study (2006) (0)
Abstract 84: Impact of Education on Dual Antiplatelet Therapy Adherence (2012) (0)
Opening the window of facilitated percutaneous coronary intervention in acute infarction: The role of combined IIb/IIIa inhibition and thrombolytic therapy (2003) (0)
The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial. (2018) (0)
GENDER-BASED CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING XIENCE V® EVEROLIMUS-ELUTING STENTS: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY (2011) (0)
Reduction of ischemic ST deviation and regional wall motion dysfunction during PTCA of the Left Anterior Descending Coronary Artery (LAD) with Synchronized Coronary Sinus Retroperfusion (SRP) (1996) (0)
Performance of an A u t o m a t e d Real-t ime ST-Segment Analysis Program to Detect Coronary Occlusion and Reperfusion (2005) (0)
Electrocardiographic patterns of impending coronary closure independent of unstable anginal symptoms (1989) (0)
Novel Design Changes in DES Not Necessarily Better until Proven So (2012) (0)
PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
Restenosis, statistics, and reasonable inferences. Authors' replay (2006) (0)
Comparison of Primary Percutaneous oronary Intervention With Combined Proximal mbolic Protection and Thrombus Aspiration Versus rimary Percutaneous Coronary Intervention Alone n ST-Segment Elevation Myocardial Infarction (0)
Evaluation of paclitaxel eluting stents in single and multivessel coronary artery disease using established and novel stent platforms: An interim analysis of the randomized, blinded COSTAR II trial (2006) (0)
Abstract 14862: Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention (2011) (0)
ST-elevation no myocardial infarction (2017) (0)
P1022Upstream therapy using preoperative renin-angiotensin system inhibitors in prevention of postoperative atrial fibrillation and adverse events: a collaborative pooled-analysis over 27,000 patients (2019) (0)
Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry". (2015) (0)
INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
Abstract 2032: Mechanistic and Prognostic Implications of "Burst" Ventricular Arrhythmias and Their Precise Timing after TIMI 3 Reperfusion in Anterior ST Elevation Myocardial Infarction (2007) (0)
ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Analysis intheTAMI7Study Performance ofa Noninvasive MethodforReal-Time Detection ofFailed Myocardial Reperfusion (2011) (0)
Abstract 19050: Does Type of Culprit Lesion Matter in Patients with Acute Coronary Syndrome and Prior Coronary Artery Bypass Graft Surgery Undergoing Percutaneous Coronary Intervention? (2012) (0)
Alvin C. Wyman, M.D (1984) (0)
Defining QT / QTc Prolongation During ST-Elevation Myocardial Infarction and Reperfusion (2014) (0)
Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry (2012) (0)
Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
Abstract 15433: Prevalence and Natural History of Moderate or Severe Mitral Regurgitation: an Observational Study from a Single Center (2011) (0)
Treatment of smaller coronary vessels with XIENCE V® everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study (2011) (0)
Abstract 20347: Low Clinical Event Rates in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V(R) Everolimus-Eluting Stents: One-Year Results from the XIENCE V USA Study (2010) (0)
CRT-100.35 Predictors of Early Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPARE CRUSH Trial (2022) (0)
Clinical outcomes in treatment of chronic total occlusions with the XIENCE V everolimus-eluting stent system in real-world patients: one-year pooled results from the XIENCE V USA and SPIRIT V studies (2013) (0)
TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group. (2022) (0)
OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
Direct stenting versus stenting after predilatation in STEMI patients with high thrombus burden: a subanalysis from the randomized COMPARE CRUSH trial (2022) (0)
Recurrence of ST elevation after early reperfusion as a marker of prognosis in ST elevation infarction (2003) (0)
Novel applications of ECG monitoring for the quantification of noetic phenomena (1999) (0)
TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL (2022) (0)
Abstract 12989: Generalizability of Quantitative Angiographic In-Segment Late Lumen Loss Imaging in Eastern and Western Populations: Can We Facilitate Global Drug Eluting Stent Evaluation? (2014) (0)
Abstract 20469: Predictors of 1-Year Clinical Outcomes in Real World Patients from XIENCE V(R) USA Study. (2010) (0)
The Monitoring and Actualization of Noetic TRAining the MANTRA Study, a randomized controlled study of healing interventions. (1997) (0)
TCT-674 Implication of peri-procedural biomarker elevation after stent implantation: analysis from the pooled XIENCE V trials (2012) (0)
TCT-455 Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent (2013) (0)
P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
Reporting an Erratum in the article, “Preexcitation and Myocardial Infarction: Conditions with Confusing Electrocardiographic Manifestations”, November/December issue (41/6) (2009) (0)
EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS (2020) (0)
TCT-304 Long term clinical outcomes in acute coronary syndrome patients at high bleeding risk undergoing PCI with implantation of everolimus-eluting stents: Results from the Patient-Level Pooled Analysis of EES Post Approval Studies. (2018) (0)
Performance of a novel statistical filter to compensate for data gaps during continuous ST-segment monitoring (2005) (0)
TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
A Comparison of Static Serial vs Continuous ST-Segment Recovery to Predict Outcome After Lytics for MI (1998) (0)
Abstract 11123: Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic Dysfunction (2014) (0)
Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy (1996) (0)
Conversations in cardiology: Late career transitions—Retool, retire, refocus (2022) (0)
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007 (2009) (0)
TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients. (2016) (0)
TCT-421 Prevalence and treatment patterns for in-stent restenosis: A single center report from the Duke Databank for Cardiovascular Disease (2017) (0)
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. (2022) (0)
Stent Thrombosis in BMS and DES More issues than answers (0)
The MANTRA II study – Authors' reply (2005) (0)
Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies (2007) (0)
TCT-844 Long term risk for major bleeding and ischemic events after PCI with implantation of everolimus-eluting stents: A Pooled-level Analysis of 8,020 Patients (2018) (0)
Reperfusion arrhythmia bursts predict larger infarct size in STEMI patients undergoing primary percutaneous coronary intervention despite optimal epicardial and microvascular flow (2013) (0)
The incremental prognostic value of therapy responsive continuous 12-lead ST-segment variables to baseline clinical descriptors for the prediction of clinical outcome after acute myocardial infarction (1999) (0)
TCT-484: Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial (2016) (0)
THE IMPACT OF RIGOROUS QUALITY IMPROVEMENT ON 3D ECHOCARDIOGRAPHY IMAGE AND DATA QUALITY IN AN INTERNATIONAL MULTISITE RANDOMIZED TRIAL (2017) (0)
Prayer and Cardiovascular Disease (2004) (0)
TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
The impact of XIENCE V on health status in a variety of angiographic subsets using the Seattle Angina Questionnaire (2010) (0)
AS-3: Immediate ST-Segment Resolution Is Associated with Left Ventricular Function and Infarct Size Measured by Cardiovascular Magnetic Resonance in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention (2009) (0)
In memorium: Nancy B. Wagner, 1949–1991 (1991) (0)
TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
ST Segment Monitoring Substudy patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I Prognostic significance of ST segment shift early after resolution of ST elevation in (2011) (0)
TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
Transluminal Coronary Angioplast (2005) (0)
TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study (2012) (0)
Toward a better system for the sustainable development of objective performance goals for peripheral vascular interventions. (2021) (0)
Permanently implantable diagnostic computerized devices: where is the regulatory rar? (2004) (0)
DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
Chapter 22 – Prayer and Cardiovascular Disease (2005) (0)
Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
P2262Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials (2018) (0)
PREDICTING MAJOR ADVERSE CARDIAC EVENTS AND INFARCT SIZE USING ST-SEGMENT RESOLUTION AS A CONTINUOUS RATHER THAN A DICHOTOMOUS VARIABLE IN PATIENTS ACHIEVING THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE III AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFA (2010) (0)
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. (2022) (0)
TCT CONNECT-376 A Novel Machine Learning Algorithm Enhances Prediction of Target Lesion Failure: An Analysis of 4,983 Patients From the XIENCE V USA Database (2020) (0)
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction - One-year follow-up results of the COMPARE CRUSH trial: One-year results from the COMPARE CRUSH trial. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mitchell W. Krucoff?

Mitchell W. Krucoff is affiliated with the following schools:

Columbia University
Duke University

Mitchell W. Krucoff's Academic­Influence.com Rankings

Why Is Mitchell W. Krucoff Influential?

Mitchell W. Krucoff's Published Works

Published Works

What Schools Are Affiliated With Mitchell W. Krucoff?

Mitchell W. Krucoff's AcademicInfluence.com Rankings